Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium 80S ribosome is the cytosolic protein synthesis machinery of the malaria parasite, essential for its growth and survival across multiple life cycle stages (Sun et al., 2015, Science). It is a large ribonucleoprotein complex consisting of a 40S small subunit and a 60S large subunit that translate messenger RNA into proteins. Although it shares a general architecture with the human 80S ribosome, the Plasmodium version contains unique ribosomal RNA expansion segments and protein isoforms that create parasite-specific structural pockets (Wong et al., 2014, eLife). These differences are exploited in drug discovery to develop selective inhibitors that can distinguish between the parasite and host translation machinery. Compounds such as emetine and mefloquine have been shown to bind to the Plasmodium 80S ribosome, effectively blocking translation elongation or translocation (Wong et al., 2014, eLife). Targeting this ribosome is a validated strategy for developing potent, multi-stage antimalarials, though achieving high selectivity to avoid host toxicity remains a primary challenge. Modern research utilizes high-resolution cryo-electron microscopy to identify these species-specific binding sites for the design of next-generation therapeutics.
Inhibition of protein synthesis by blocking translation elongation, translocation, or the decoding process on the cytosolic 80S ribosome (Wong et al., 2014, eLife).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium 80S ribosome (Pf80S).